[Escribaaquí]

PROGRAMACIENTÍFICOAtrialSignals20175-8octubre2017

Valencia

2

ATRIALSIGNALS2017-VALÈNCIAResearch and development has brought many significant advances to electrophysiologicalexaminations of the atria in recent years. Electroanatomical mapping systems reduceradiation,multichannelcathetersallowforsimultaneoushighdensitymapping,andcomputermodelingenhancescomprehensionofsignalgenerationandthemechanismsofarrhythmias.However,despitealltheseefforts,atrialfibrillationstillposesamajorproblemforclinicians.TheaimoftheAtrialSignalssymposiumistobringtogetherleadingexpertsfromtheclinical,physiological and engineering fields in the characterization, diagnosis and management ofatrial fibrillation in order to share cutting edge knowledge and exchange ideas aboutmechanisms that drive AF, controversies in AF management, and new technologies fordecision-making,amongotheraspects.Thehighlevelofkeynotespeakersandthesuccessofthepastsymposiumorganizedin2015byOlafDössel andClausSchmittencouragedus toorganize, jointlywithouresteemedpastorganizers.This second edition will be organized as cooperation by two institutions, both reputableinstitutionsinthefieldofatrialmodeling,signalprocessingandmedicaltreatment:UniversitatPolitècnicadeValència(www.upv.es)HospitalUniversitariLaFe(www.hospital-lafe.com)Co-Chairs:

3

KeynoteSpeakers:

4

KeynoteSpeakers:

5

KeynoteSpeakers:

6

THURSDAY5OCTOBER2017

FrontiersinAFibmanagement:Newpharmacologicaladvances&promisesofinvasivestrategies

15:30WelcomeToAtrialSignals2017J.MilletandJ.Oscà15:35Newantiarrhythmicdrugs.Whatiscoming?EvaDelpón16:00Cardioversionbydrugs.Whatcannon-invasiveatrialsignalanalysistellus?JoseMillet16:25Frontiersinstrokeprevention:Atrialhigh-rateepisodes(AHRE)detectedwithmobiledevices:HowmuchAFibisneededtostartanticoagulation.CarlosMorillo16:50Isablationatreatmentthatisreallyimprovingprognosis?DouglasL.Packer17:15—17:40Coffeebreak17:45ShouldweinterruptormaintainanticoagulanttherapyafterAFibablation?F.Gaita18:10Leftatrialappendageocclusion:isitarealalternativetooralanticoagulanttherapy?CanitbecombinedwithAFibablation?

7

PetrNeuzil18:35—19:05PanelDiscussionModerator:JoaquínOscàPanelists:PreviousspeakersandDavidFigueiras

FRIDAY6OCTOBER2017

MechanismsofAF08:30MechanismsofAFib:recentadvances08:55Rotorand focal source identification (spatio-temporalanalysisofpatterns)andwhatare therealdriversofAFib?SanjivNarayan09:20Endo-epicardialdissociationinAFibUlrichSchotten09.45Computermodelling of AFib:What is it good for? Canwe reach out to personalize therapyplanning?OlafDössel10:25Thepotentialroleofre-entries.JLMerino10:50PanelDiscussionModerator:OlafDösselMri&Fibrosis11:30Coffeebreak11:20Atrialcardiomyopathies-isitjustamatteroffibrosis?AndreasGoette

8

11:45DetectionoffibrosisandimportanceinAFibNassirMarrouche12:35CorrelationofMRIdetectedfibrosisandsustrateendocardialmapping.HowtointegratebothtechniquesMontLL13:00Spatialrelationshipoffocaldrivers,rotorsandfibrosisinpatientswithpersistentAFib.VadimFedorov13:20Lunchbreak14:50PanelDiscussionModerator:LuisMartíBonmatí15:20POSTERSESSION16:50CoffeebreakMapping17:20Emergingmappingtechnologies-Wherearewenowandwherearewegoing?AtulVerma17:45InvasivemappingofdriversinAFibSpitzner18:10Non-invasivemappingofdriversinAFib.ContributionsofECGimagingHaissaguerre18:35

9

Fromrawdatatoatrialactivationmaps.Diagnosticpitfallsandlimitations.Whatcanwereallytrustin?TobiasOesterlein18:55PanelDiscussionModerators:ClausSchmitt,JMGuerra

SATURDAY7OCTOBER2017

TransferringKnowledge,FromMechanismsToAblation08:30DowereallyknowwhatwearedoinginAFibablation.MarkO’Neill08:55AFibfocalsourcesablation:alternative,complementtoPVI,oruselessSabineErnst09:20DetectionofatrialfibrosisandablationplanningThomasArentz09.45Non-pulmonaryveintriggerablationinAFibDr.PasqualeSantangeli10:10Coffeebreak10:40PredictivemodelsofAFib:ablationoutcomesfromdataanalysis11:05PanelDiscussionModerators:J.Brugada,Paponne*NewTechnologies,NewSynergies11:30WhatthefutureholdsandwhatweneedfromengineersC.Paponne

10

11:55MobiledevicesandAppsandthepotentialimpactonAFibmonitoringandtherapyFrancisWhite12:20Imaging and mapping – research (real time MRI, optical mapping, μCT, μMRI, confocalmicroscopy)andwhatdowelearnaboutthebasicsofAFib?RobMacleod12:45NovelglobalultrasoundimagingandcontinuousdipoledensitymappingRichardSchilling13:10PanelDiscussionModerator:JMilletOtherInformationofInterest:TheaimoftheAtrialSignalssymposiumistobringtogetherleadingexpertsfromtheclinical,physiological and engineering fields in the characterization, diagnosis and management ofatrial fibrillation in order to share cutting-edge knowledge and exchange ideas aboutmechanisms that drive AF, controversies in AF management, and new technologies fordecision-making,amongotheraspectsThe target audience of this event includes: Academics, Doctors and interns, Engineers andPhDsandMastersstudents